Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.
JCIL reported strong Q1CY26 standalone revenue growth of 162% YoY. Management is integrating global metal businesses into the Indian entity, shifting focus from downstream to higher-potential upstream steel technologies like Volteron.
Protean delivered record FY26 consolidated revenue of ₹998cr, up 18.7% YoY, with EBITDA margins expanding to 17.6%. Strategy focuses on scaling New Businesses and international DPI expansion.
Akiko Global reported Q4 FY26 revenue of ₹57.7cr (+48% YoY) and FY26 revenue of ₹172.6cr, transitioning from traditional distribution to a technology-driven fintech platform.
Sai Parenterals reports Q4 FY26 consolidated revenue of ₹198cr and EBITDA of ₹29cr, following the Noumed acquisition. Standalone FY26 PAT grew 64% YoY.
Transcript from Q4 FY26 analyst meet. Standalone volume grew 24% YoY to 23.6 BU for the quarter; annual volume up 12% to 92.8 BU. Management focus shifting to short-term trades and renewables.
AIA Engineering delivered strong Q4 FY26 performance with PAT rising 38% YoY. Company maintained high EBITDA margins near 40% driven by cost efficiencies and product mix.
GE Vernova T&D India reported a transformative FY26 with record order intake and significant margin expansion driven by India's energy transition and robust export demand.
Harshdeep Hortico reported H2 FY26 growth despite raw material and LPG supply headwinds. Strategy focuses on B2B expansion, new high-margin product verticals like fountains, and operational efficiency.
DICABS delivered a turnaround in FY26, with Revenue reaching ₹1,91,010 Lakhs (up 71% YoY) and PAT hitting ₹15,817 Lakhs (up 355% YoY). Strategy focuses on high-margin EHV/MV cables and backward integration.
Entero Healthcare delivered on its FY26 guidance with 31.5% like-for-like revenue growth and 4% EBITDA margins. Management transitioned to organic growth and profitability, focusing on higher-margin MedTech segments.
CONCOR achieved record throughput of 5.58M TEUs despite global trade disruptions. While Exim revenue hit record highs, domestic performance suffered from geopolitical conflicts and container shortages.
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.
Prince Pipes reported robust Q4 FY26 performance with 23% volume growth and 13% EBITDA margins, driven by operational efficiency, value-added products, and strategic expansion into the Bathware segment.
Eldeco Housing & Industries delivered record FY26 operational performance with 120% YoY booking value growth and 39% collection growth, driven by successful project launches in Lucknow.
HMA Agro reported significant growth for FY26, with consolidated revenue reaching ₹69,165 Mn, up 34.75% YoY. Performance driven by frozen buffalo meat exports and diversification into seafood, rice, and pet food segments.
ACE delivered record Q4FY26 revenue with margins at 16%. Management is focusing on sustaining profitability through price hikes and a new 50:50 JV with KATO Japan for heavy cranes.
Q4FY26 revenue grew 9.6% YoY to ₹405cr with significant margin expansion. FY26 revenue was ₹1,441cr, down 1.5% due to Payment Solutions headwinds, offset by IoT growth.
Banswara Syntex reported FY26 total income of ₹1,370cr with 22.5% EBITDA growth to ₹144cr. Strategy focuses on increasing Fabric/Garment revenue share to 70% to boost margins.
Aarti Pharmalabs reported FY26 standalone revenue of INR 17,976 Mn with a 23% EBITDA margin. Strategy focuses on CDMO expansion and backward integration for Xanthine derivatives.
Solarworld Energy Solutions delivered massive growth in Q4FY26, with total income up 239% YoY to ₹6,069.5 Mn and PAT up 420% to ₹490.6 Mn, driven by aggressive EPC and BESS execution.
Khadim India reported Q4FY26 revenue of ₹835.6mn and PAT of ₹7.7mn. The company is transitioning to an asset-light model with 100% outsourcing and 78% franchise-based retail presence.
Speciality Restaurants reported Q4 FY26 revenue growth of 13.65% and PAT surge of 44.20% YoY. Strategy focuses on core Asian brands and transitioning kitchens to induction to mitigate fuel inflation.
BCL Industries reported Q4 FY26 revenue of ₹611 Cr with 9.5% EBITDA margins. Management is pivoting from packaged oil to high-margin distillery and oil trading verticals.
Orchid Pharma reports FY26 standalone revenue of ₹811 Cr and PAT of ₹45 Cr, focusing on transitioning from a turnaround to an integrated cephalosporin platform with major capex in 7ACA.